Compare CVS Health Corp (CVS) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Johnson & Johnson — how do they compare? CVS Health Corp trades at $93.62 (market cap $119.58B), while Johnson & Johnson trades at $258.54 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 5.2× CVS Health Corp's market cap, and CVS Health Corp pays the higher dividend (2.84%). Which is the better fit depends on your goals.
| CVS | JNJ | |
|---|---|---|
Market Cap | $119.58B | $626.09B |
Sector | Health | Health |
52-Week High | $110.60 | $267.24 |
52-Week Low | $65.51 | $172.78 |
Enterprise Value | $181.93B | $654.37B |
Dividend Yield | 2.84% | 2.06% |
Volume | — | 6,156,228 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
